Biohaven Pharmaceuticals, INC.
A biopharmaceutical company.
Based in CT
AI Overview
With $730K in lobbying spend across 15 quarterly filings, Biohaven Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $20K |
| 2023 | $230K |
| 2024 | $240K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Biohaven Pharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Policies, proposals, and FDA regulation of pharmaceuticals in disease areas served by Biohaven.
Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.